Exane Derivatives Teleflex Inc Transaction History

Exane Derivatives

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$244.93 - $354.82 $3,184 - $4,612	-13 Closed	0 $0
Q1 2022 Apr 22, 2022	BUY	$295.56 - $354.83 $3,842 - $4,612	13 New	13 $4,000
Q4 2021 Jan 28, 2022	SELL	$289.48 - $383.27 $883,203 - $1.17 Million	-3,051 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$360.3 - $422.82 $9,367 - $10,993	-26 Reduced 0.84%	3,051 $1.15 Million
Q2 2021 Jul 28, 2021	SELL	$385.96 - $443.85 $9,649 - $11,096	-25 Reduced 0.81%	3,077 $1.24 Million
Q1 2021 Apr 30, 2021	SELL	$372.25 - $429.44 $59,560 - $68,710	-160 Reduced 4.9%	3,102 $1.29 Million
Q4 2020 Jan 27, 2021	BUY	$318.23 - $411.57 $900,272 - $1.16 Million	2,829 Added 653.35%	3,262 $1.34 Million
Q3 2020 Oct 08, 2020	BUY	$326.7 - $408.18 $141,461 - $176,741	433 New	433 $147,000
Q3 2020 Oct 06, 2020	SELL	$326.7 - $408.18 $61,419 - $76,737	-188 Closed	0 $0
Q2 2020 Jul 10, 2020	SELL	$279.8 - $376.58 $83,940 - $112,974	-300 Reduced 61.48%	188 $68,000
Q1 2020 Apr 17, 2020	BUY	$225.31 - $395.14 $57,454 - $100,760	255 Added 109.44%	488 $142,000
Q4 2019 Jan 22, 2020	BUY	$316.75 - $376.44 $72,535 - $86,204	229 Added 5725.0%	233 $87,000
Q3 2019 Oct 15, 2019	SELL	$329.13 - $371.65 $100,055 - $112,981	-304 Reduced 98.7%	4 $1,000
Q1 2019 Apr 24, 2019	BUY	$246.2 - $304.96 $37,176 - $46,048	151 Added 96.18%	308 $0
Q4 2018 Jan 31, 2019	BUY	$229.54 - $275.63 $36,037 - $43,273	157 New	157 $40,000

565

45.7M

18.3K

10.2K

Ticker TFX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,906,400
Market Cap $8.36B
Description
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access ...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.